Financials Athersys, Inc.

Equities

ATHXQ

US04744L2051

Biotechnology & Medical Research

Market Closed - OTC Markets 03:42:02 2024-04-26 pm EDT 5-day change 1st Jan Change
0.0044 USD 0.00% Intraday chart for Athersys, Inc. -2.22% -78.00%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 214.5 204.1 192.7 346 212.3 14.16
Enterprise Value (EV) 1 185.2 153.1 158.3 295.1 184.7 13.81
P/E ratio -6.24 x -8 x -4.19 x -4.17 x -2.31 x -0.14 x
Yield - - - - - -
Capitalization / Revenue 57.9 x 8.4 x 34.2 x 240 x 38.5 x 2.66 x
EV / Revenue 50 x 6.3 x 28.1 x 205 x 33.5 x 2.59 x
EV / EBITDA -5.68 x -6.17 x -3.54 x -3.81 x -2.16 x -0.21 x
EV / FCF -12.8 x -12.4 x -7.23 x -8.92 x -4.09 x -0.64 x
FCF Yield -7.83% -8.09% -13.8% -11.2% -24.5% -157%
Price to Book 9.45 x 4.82 x 8.45 x 11.3 x 13.4 x -0.63 x
Nbr of stocks (in thousands) 4,741 5,670 6,267 7,908 9,409 16,861
Reference price 2 45.25 36.00 30.75 43.75 22.56 0.8400
Announcement Date 3/15/18 3/15/19 3/16/20 3/25/21 3/15/22 4/3/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 3.708 24.29 5.633 1.44 5.514 5.325
EBITDA 1 -32.6 -24.81 -44.79 -77.44 -85.63 -65.55
EBIT 1 -33.28 -25.66 -45.49 -78.33 -86.56 -66.97
Operating Margin -897.6% -105.64% -807.53% -5,439.72% -1,569.79% -1,257.63%
Earnings before Tax (EBT) 1 -32.24 -24.28 -44.58 -78.76 -86.96 -72.53
Net income 1 -32.24 -24.28 -44.58 -78.76 -86.96 -72.53
Net margin -869.5% -99.97% -791.44% -5,469.79% -1,576.99% -1,362.14%
EPS 2 -7.250 -4.500 -7.347 -10.50 -9.750 -6.072
Free Cash Flow 1 -14.5 -12.38 -21.91 -33.1 -45.2 -21.66
FCF margin -390.99% -50.97% -389.01% -2,298.58% -819.82% -406.73%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/15/18 3/15/19 3/16/20 3/25/21 3/15/22 4/3/23
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales 1 - 4.792 0.722 2.912 - - 0.032 - 0.049 -
EBITDA -21.85 -16 - -22.13 -23.64 -16.1 - - - -
EBIT 1 -22.57 -16.22 -21.68 -22.38 -24.26 -16.71 -13.66 - -12.99 -7.78
Operating Margin - -338.52% -3,002.08% -768.48% - - -42,687.5% - -26,506.12% -
Earnings before Tax (EBT) -22.6 -16.18 -21.71 -22.22 - - - - - -
Net income 1 -22.6 -16.18 -21.71 -22.22 -23.65 -13.67 -13 - -12.92 -3.771
Net margin - -337.58% -3,007.06% -762.91% - - -40,628.12% - -26,375.51% -
EPS 2 -2.500 -1.750 -2.250 -2.250 -2.250 -1.150 -0.8300 -0.4300 -0.6200 -0.1500
Dividend per Share - - - - - - - - - -
Announcement Date 8/9/21 11/15/21 3/15/22 5/6/22 8/11/22 11/14/22 3/31/23 5/15/23 8/16/23 11/16/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - -
Net Cash position 1 29.3 51.1 34.4 50.9 27.6 0.35
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -14.5 -12.4 -21.9 -33.1 -45.2 -21.7
ROE (net income / shareholders' equity) -187% -73% -134% -288% -364% 1,939%
ROA (Net income/ Total Assets) -79% -33.7% -55% -96.6% -90.2% -95.2%
Assets 1 40.8 72.16 81.07 81.55 96.36 76.18
Book Value Per Share 2 4.790 7.470 3.640 3.880 1.690 -1.330
Cash Flow per Share 2 6.000 8.850 5.480 6.380 3.850 0.5000
Capex 1 0.29 1.53 0.58 1.16 1.36 0.4
Capex / Sales 7.69% 6.31% 10.28% 80.69% 24.66% 7.46%
Announcement Date 3/15/18 3/15/19 3/16/20 3/25/21 3/15/22 4/3/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. ATHXQ Stock
  4. Financials Athersys, Inc.